has a place in the effort to avert acute attacks; however, its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Arterial-Blood Studies during Treatment of Severe Refractory Bronchial Asthma in Case 2 on May 17, after Theophylline and Epinephrine (1), at 8:00 A.M., when the Asthma Was Refractory to ...

The following is a summary of “Clinical remission attainment, definitions, and correlates among patients with severe asthma ...

Emerging research suggests that certain diabetes medications could offer benefits beyond blood sugar control, potentially ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca ... Airsupra was found to significant reduce the risk of severe exacerbations compared to albuterol in patients with ...

"For me, preventing exacerbations, and particularly those that lead to hospitalisations, is a treatment priority for the people I see with severe asthma," he added. "Not only are exacerbations ...

A recent study published in The Journal of Allergy and Clinical Immunology: In Practice found that gestational diabetes ...

Pegtarazimod is under clinical development by ReAlta Life Sciences and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury.